Measurement of the Attachment and Assembly of Small Amyloid-β Oligomers on Live Cell Membranes at Physiological Concentrations Using Single-Molecule Tools

Selkoe, 1991, The molecular pathology of Alzheimer's disease, Neuron, 6, 487, 10.1016/0896-6273(91)90052-2 Irvine, 2008, Protein aggregation in the brain—the molecular basis for Alzheimer's and Parkinson's diseases, Mol. Med., 14, 451, 10.2119/2007-00100.Irvine Wong, 1985, Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related, Proc. Natl. Acad. Sci. USA, 82, 8729, 10.1073/pnas.82.24.8729 Roychaudhuri, 2009, Amyloid β-protein assembly and Alzheimer disease, J. Biol. Chem., 284, 4749, 10.1074/jbc.R800036200 Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 Haass, 1992, Amyloid β-peptide is produced by cultured cells during normal metabolism, Nature, 359, 322, 10.1038/359322a0 Byström, 2008, Disordered proteins: biological membranes as two-dimensional aggregation matrices, Cell Biochem. Biophys., 52, 175, 10.1007/s12013-008-9033-4 Arispe, 1993, Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum, Proc. Natl. Acad. Sci. USA, 90, 567, 10.1073/pnas.90.2.567 Rhee, 1998, Amyloid β protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel, J. Biol. Chem., 273, 13379, 10.1074/jbc.273.22.13379 Quist, 2005, Amyloid ion channels: a common structural link for protein-misfolding disease, Proc. Natl. Acad. Sci. USA, 102, 10427, 10.1073/pnas.0502066102 Lal, 2007, Amyloid β ion channel: 3D structure and relevance to amyloid channel paradigm, Biochim. Biophys. Acta, 1768, 1966, 10.1016/j.bbamem.2007.04.021 Arispe, 1994, The ability of amyloid β-protein [A βP (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer's disease, Ann. N. Y. Acad. Sci., 747, 256, 10.1111/j.1749-6632.1994.tb44414.x Lin, 1999, Amyloid β protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles, Biochemistry, 38, 11189, 10.1021/bi982997c Jang, 2008, New structures help the modeling of toxic amyloidβ ion channels, Trends Biochem. Sci., 33, 91, 10.1016/j.tibs.2007.10.007 McLaurin, 1996, Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity, J. Biol. Chem., 271, 26482, 10.1074/jbc.271.43.26482 Widenbrant, 2006, Lipid-induced β-amyloid peptide assemblage fragmentation, Biophys. J., 91, 4071, 10.1529/biophysj.106.085944 Small, 2007, The β-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor, J. Neurochem., 101, 1527, 10.1111/j.1471-4159.2006.04444.x Garai, 2008, Quasihomogeneous nucleation of amyloid β yields numerical bounds for the critical radius, the surface tension, and the free energy barrier for nucleus formation, J. Chem. Phys., 128, 045102, 10.1063/1.2822322 Sengupta, 2003, The amyloid β peptide (Aβ (1-40)) is thermodynamically soluble at physiological concentrations, Biochemistry, 42, 10506, 10.1021/bi0341410 Sahoo, 2009, On the stability of the soluble amyloid aggregates, Biophys. J., 97, 1454, 10.1016/j.bpj.2009.05.055 Selkoe, 2008, Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior, Behav. Brain Res., 192, 106, 10.1016/j.bbr.2008.02.016 Garai, 2007, Zinc lowers amyloid-β toxicity by selectively precipitating aggregation intermediates, Biochemistry, 46, 10655, 10.1021/bi700798b Glabe, 2008, Structural classification of toxic amyloid oligomers, J. Biol. Chem., 283, 29639, 10.1074/jbc.R800016200 Walsh, 1997, Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate, J. Biol. Chem., 272, 22364, 10.1074/jbc.272.35.22364 Kayed, 2009, Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer, J. Biol. Chem., 284, 4230, 10.1074/jbc.M808591200 Walsh, 2007, A β oligomers—a decade of discovery, J. Neurochem., 101, 1172, 10.1111/j.1471-4159.2006.04426.x Lashuel, 2002, Neurodegenerative disease: amyloid pores from pathogenic mutations, Nature, 418, 291, 10.1038/418291a Hoshi, 2003, Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β, Proc. Natl. Acad. Sci. USA, 100, 6370, 10.1073/pnas.1237107100 Kayed, 2004, Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases, J. Biol. Chem., 279, 46363, 10.1074/jbc.C400260200 Shankar, 2008, Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory, Nat. Med., 14, 837, 10.1038/nm1782 Hung, 2008, Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimers correlate with neurotoxicity, J. Neurosci., 28, 11950, 10.1523/JNEUROSCI.3916-08.2008 Lesné, 2006, A specific amyloid-β protein assembly in the brain impairs memory, Nature, 440, 352, 10.1038/nature04533 Walsh, 2002, Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo, Nature, 416, 535, 10.1038/416535a Parodi, 2010, β-Amyloid causes depletion of synaptic vesicles leading to neurotransmission failure, J. Biol. Chem., 285, 2506, 10.1074/jbc.M109.030023 Lue, 1999, Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol., 155, 853, 10.1016/S0002-9440(10)65184-X Shankar, 2009, Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life, Neurobiol. Dis., 36, 293, 10.1016/j.nbd.2009.07.021 Puzzo, 2008, Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus, J. Neurosci., 28, 14537, 10.1523/JNEUROSCI.2692-08.2008 Townsend, 2006, Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers, J. Physiol., 572, 477, 10.1113/jphysiol.2005.103754 Lacor, 2004, Synaptic targeting by Alzheimer's-related amyloid β oligomers, J. Neurosci., 24, 10191, 10.1523/JNEUROSCI.3432-04.2004 Bateman, 2009, Two distinct conformations of Aβ aggregates on the surface of living PC12 cells, Biophys. J., 96, 4260, 10.1016/j.bpj.2009.01.056 Wakabayashi, 2007, Formation of amyloids by Aβ-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol, J. Mol. Biol., 371, 924, 10.1016/j.jmb.2007.06.008 Magde, 1972, Thermodynamic fluctuations in a reacting system—measurement by fluorescence correlation spectroscopy, Phys. Rev. Lett., 29, 705, 10.1103/PhysRevLett.29.705 Magde, 1974, Fluorescence correlation spectroscopy. II. An experimental realization, Biopolymers, 13, 29, 10.1002/bip.1974.360130103 Maiti, 1997, Fluorescence correlation spectroscopy: diagnostics for sparse molecules, Proc. Natl. Acad. Sci. USA, 94, 11753, 10.1073/pnas.94.22.11753 Sengupta, 2003, Measuring size distribution in highly heterogeneous systems with fluorescence correlation spectroscopy, Biophys. J., 84, 1977, 10.1016/S0006-3495(03)75006-1 Sengupta, 2002, Measuring diffusion in cell membranes by fluorescence correlation spectroscopy, Methods, 27, 374, 10.1016/S1046-2023(02)00096-8 Haupts, 1998, Dynamics of fluorescence fluctuations in green fluorescent protein observed by fluorescence correlation spectroscopy, Proc. Natl. Acad. Sci. USA, 95, 13573, 10.1073/pnas.95.23.13573 Culbertson, 2002, Diffusion coefficient measurements in microfluidic devices, Talanta, 56, 365, 10.1016/S0039-9140(01)00602-6 Chen, 1999, The photon counting histogram in fluorescence fluctuation spectroscopy, Biophys. J., 77, 553, 10.1016/S0006-3495(99)76912-2 Saffman, 1975, Brownian motion in biological membranes, Proc. Natl. Acad. Sci. USA, 72, 3111, 10.1073/pnas.72.8.3111 Gambin, 2006, Lateral mobility of proteins in liquid membranes revisited, Proc. Natl. Acad. Sci. USA, 103, 2098, 10.1073/pnas.0511026103